[1] 陈 磊, 徐杰茹, 刘 艳, 等. 2005～2015年中国肾癌发病趋势分析 [J]. 华中科技大学学报(医学版), 2022, 51(1): 58-62,7.
[2] Hsieh J J, Purdue M P, Signoretti S, et al. Renal cell carcinoma [J]. Nat Rev Dis Primers, 2017, 3: 17009.
[3] Moch H, Cubilla A L, Humphrey P A, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours [J]. Eur Urol, 2016, 70(1): 93-105.
[4] Cairns P. Renal cell carcinoma [J]. Cancer Biomark, 2010, 9(1-6): 461-473.
[5] Gill A J, Hes O, Papathomas T, et al. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients [J]. Am J Surg Pathol, 2014, 38(12): 1588-1602.
[6] Vanharanta S, Buchta M, McWhinney S R, et al. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma [J]. Am J Hum Genet, 2004, 74(1): 153-159.
[7] Moch H, Cubilla A L, Humphrey P A, 等. 2016年WHO泌尿系统和男性生殖器官肿瘤分类——第一部分:肾、阴茎和睾丸肿瘤 [J]. 影像诊断与介入放射学, 2018, 27(1): 65-72.
[8] 高大林, 贺慧颖. 琥珀酸脱氢酶复合物变异在肿瘤病理诊断中的意义 [J]. 中华病理学杂志, 2021, 50(2): 159-163.
[9] 肖 芹, 陈 静, 刘 丹, 等. 琥珀酸脱氢酶缺陷型肾细胞癌的临床病理分析 [J]. 中华病理学杂志, 2019, 48(10): 796-798.
[10] Kuroda N, Yorita K, Nagasaki M, et al. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects [J]. Pol J Pathol, 2016, 67(1): 3-7.
[11] 赵 醒, 申兴斌. 具有透明细胞乳头状特征的SDH缺陷型肾细胞癌1例并文献复习 [J]. 临床与实验病理学杂志, 2020, 36(3): 357-359.
[12] 林 昊, 李浩然, 谭万龙. 琥珀酸脱氢酶缺陷型肾癌1例 [J]. 解放军医学院学报, 2020, 41(1): 81-83.
[13] Jiang Q, Zhang Y, Zhou Y H, et al. A novel germline mutation in SDHA identified in a rare case of gastrointestinal stromal tumor complicated with renal cell carcinoma [J]. Int J Clin Exp Pathol, 2015, 8(10): 12188-12197.
[14] 王桃丽, 曹 云, 陈栋良. 琥珀酸脱氢酶缺陷型肾细胞癌的临床病理特征 [J]. 临床与病理杂志, 2021, 41(1): 233-239.
[15] 肾上腺意外瘤多学科管理专家组. 肾上腺意外瘤多学科管理专家共识 [J]. 中华内分泌外科杂志, 2021, 15(4): 325-336.
[16] 饶 秋, 夏秋媛, 周晓军, 等. 2016版 WHO 肾脏肿瘤新分类解读 [J]. 中华病理学杂志, 2016, 45(7): 435-441.
[17] McEvoy C R, Koe L, Choong D Y, et al. SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response [J]. NPJ Precis Oncol, 2018, 2: 9.
[18] Yakirevich E, Ali S M, Mega A, et al. A novel SDHA-deficient renal cell carcinoma revealed by comprehensive genomic profiling [J]. Am J Surg Pathol, 2015, 39(6): 858-863.
[19] Kamai T, Higashi S, Murakami S, et al. Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma [J]. Cancer Sci, 2021, 112(8): 3375-3387.
[20] Gill A J. Succinate dehydrogenase (SDH)-deficient neoplasia [J]. Histopathology, 2018, 72(1): 106-116.
[21] Andrews K A, Ascher D B, Pires D E V, et al. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD [J]. J Med Genet, 2018, 55(6): 384-394.